SCHEMBL2808862

SCHEMBL2808862

O=C(Nc1ccccc1)/C(=C/Sc1ccc(F)cc1)Sc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.44
RAB9A P51151 7/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
MAPT P10636 3/20 0.44
NFKB1 P19838 2/20 0.44
NFKB2 Q00653 2/20 0.44
RELA Q04206 2/20 0.44
KMT2A Q03164 6/20 0.40
POLB P06746 5/20 0.40
MEN1 O00255 5/20 0.40
MAOB P27338 1/20 0.40
EGFR P00533 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
CYP2C19 P33261 2/20 0.39
NOX1 Q9Y5S8 1/20 0.38
LMNA P02545 2/20 0.38
KCNK3 O14649 1/20 0.38
KCNK9 Q9NPC2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2808865 1.00 NPC1 (0.44) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL2811449 0.92 SMN1; SMN2 (0.43) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL12851365 0.92 SMN1; SMN2 (0.43) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL2811451 0.92 SMN1; SMN2 (0.43) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL2808537 0.88 RAB9A (0.45) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL2808535 0.88 RAB9A (0.45) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL2811362 0.83 ALDH1A1 (0.38) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL2811360 0.83 ALDH1A1 (0.38) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL2808688 0.82 RAB9A (0.47) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL2808691 0.82 RAB9A (0.47) NPC1RAB9ASMN1; SMN2MAPTNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 NPC1 3668/4885RAB9A 1842/4885SMN1; SMN2 1135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.